Clinical Trials Logo

Clinical Trial Summary

Convergence insufficiency is a common disorder of binocular vision that can appear as early as childhood after visual effort, and is often associated with a variety of symptoms such as eyestrain, headaches, blurred vision and diplopia. Treatment of symptomatic convergence insufficiency generally involves the intentional and controlled manipulation of a visual target's blur, conjugate and vergence movements around this target, with the aim of normalizing the accommodation and vergence systems and their mutual interactions. Despite the effectiveness of this treatment, compliance is not optimal, ranging from 24% to 91% in the youngest patients. One of the main challenges is to keep patients focused and interested during the potentially tedious and repetitive periods of over-convergence. In order to stimulate the patient's active participation and stable, sustained attention, a dichoptic reading application on a digital tablet has been developed to provide sustained training in ocular alignment and coordination to reduce symptoms and restore binocular function in patients with symptomatic convergence insufficiency.


Clinical Trial Description

The dichoptic reading application on a digital tablet consists in reading, with red-green anaglyph glasses, a text composed of letters or words presented both binocularly and monocularly (black and red-green, respectively) from downloaded e-books. After centralized randomization, patients will undergo either reference orthoptic rehabilitation (control group) or dichoptic treatment on a digital tablet (experimental group). The control group will receive 12 training sessions (25 minutes twice a week for 6 weeks) as part of their regular treatment in the Ophthalmology Department of the CHU de Montpellier, while the experimental group will perform self-training at home (25 min/day, 5 days a week for 6 weeks). For all participants, an initial visit and two follow-up evaluation visits (visits 2 and 3) will be scheduled 3 and 6 weeks (+ 1 week) after the start of the intervention, and will be carried out by one of the 3 other orthoptists in the Ophthalmology Department of the CHU de Montpellier. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06465615
Study type Interventional
Source University Hospital, Montpellier
Contact Marie-Céline Mrs. LORENZINI, Dr
Phone 04 67 33 50 17
Email marie-celine.lorenzini@chu-montpellier.fr
Status Not yet recruiting
Phase N/A
Start date September 1, 2024
Completion date September 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04416776 - Validation of the Utility of Strabismus Intelligent Diagnostic System
Active, not recruiting NCT06069752 - Positional Stability and Refractive Behaviour After Implantation of an IOL After Cataract Surgery
Recruiting NCT04213430 - Development and Validation of a Deep Learning System for Multiple Ocular Fundus Diseases Using Retinal Images
Recruiting NCT05622565 - Explainable Ocular Fundus Diseases Report Generation System
Completed NCT03127163 - Intraestromal Corneal Ring in Mild Keratoconus N/A
Completed NCT06291844 - Ocular Trauma and COVID-19 in Indonesia
Completed NCT04166578 - Analgetic Effect of Two Solutions of Intracameral Anesthesia During Cataract Surgery in Patients
Completed NCT03201588 - Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM) N/A
Completed NCT05279157 - Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD) Phase 2